• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SYNCARDIA SYSTEMS, LLC SYNCARDIA 70CC TEMPORARY TOTAL ARTIFICIAL HEART (TAH-T); BIVENTRICULAR REPLACEMENT DEVICE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SYNCARDIA SYSTEMS, LLC SYNCARDIA 70CC TEMPORARY TOTAL ARTIFICIAL HEART (TAH-T); BIVENTRICULAR REPLACEMENT DEVICE Back to Search Results
Model Number 397002-001
Device Problems Adverse Event Without Identified Device or Use Problem (2993); Output Problem (3005)
Patient Problems Death (1802); Hemolysis (1886); Hemorrhage, Cerebral (1889); Sepsis (2067)
Event Date 10/12/2019
Event Type  Death  
Manufacturer Narrative
The customer-reported patient hemolysis caused by a possible device malfunction was unable to be confirmed.A device malfunction could not be reproduced during investigation testing using the patient simulator because the dmc tank contains water, not blood; therefore, hemolysis cannot be assessed.During functional testing, the driver passed all test steps.The driver was further subjected to an additional 72-hour observation run in an attempt to observe a possible malfunction or change in driver performance.The driver performed as intended, and there was no evidence of a device malfunction.Syncardia is aware that all mechanical circulatory support devices may contribute to hemolysis and is continuing to study the impact of the tah-t system on the reported experience.Syncardia has completed its evaluation of this complaint and is closing this file.(b)(4).
 
Event Description
The customer, a syncardia certified hospital, reported that the patient in general was not doing well, developed hemolysis (ldh values increased over time to approximately 6000 u/l), and had a severe infection requiring intensive care treatment while supported by the companion 2 driver.The customer also reported that the patient was subsequently switched to the backup driver.The patient condition did not significantly improve, but the ldh levels came down to approximately 4000 u/l.
 
Event Description
The customer, a syncardia certified hospital, reported that the patient in general was not doing well, developed hemolysis (ldh values increased over time to approximately 6000 u/l), and had a severe infection requiring intensive care treatment while supported by the companion 2 driver.The customer also reported that the patient was subsequently switched to the backup driver.The patient condition did not significantly improve, but the ldh levels came down to approximately 4000 u/l.Subsequently the patient expired due to massive cerebral bleeding following a septic episode.
 
Manufacturer Narrative
The syncardia 70cc temporary total artificial heart (tah-t) is an implantable pulsatile biventricular replacement device that replaces a patient's native ventricles and valves and pumps blood to both the pulmonary and systemic circulation systems.The syncardia 70cc tah-t is indicated for use as a bridge to transplantation in cardiac transplant-eligible candidates at risk of imminent death from biventricular failure.The syncardia tah-t system is intended for use inside and outside the hospital.The tah-t was not returned to syncardia for evaluation.Based on the provided information there is no evidence to indicate any device malfunctions or performance issues of the device that would impact the reported event.A definitive root cause cannot be conclusively determined.This issue will be monitored and trended as part of the customer experience process.Syncardia has completed its investigation and is closing this file.(b)(4) follow-up report 1.
 
Manufacturer Narrative
Corrected sections b2 and d4.(b)(4), follow-up report 2.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SYNCARDIA 70CC TEMPORARY TOTAL ARTIFICIAL HEART (TAH-T)
Type of Device
BIVENTRICULAR REPLACEMENT DEVICE
Manufacturer (Section D)
SYNCARDIA SYSTEMS, LLC
1992 e. silverlake road
tucson, az AZ 85713
MDR Report Key9296319
MDR Text Key165600815
Report Number3003761017-2019-00309
Device Sequence Number1
Product Code LOZ
UDI-Device Identifier00858000003107
UDI-Public(01)00858000003107
Combination Product (y/n)N
PMA/PMN Number
P030011
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,u
Type of Report Initial,Followup,Followup
Report Date 11/06/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/08/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date04/30/2020
Device Model Number397002-001
Device Catalogue Number500101
Device Lot Number109481
Was Device Available for Evaluation? No
Date Returned to Manufacturer10/18/2019
Date Manufacturer Received10/12/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Death; Hospitalization; Required Intervention;
Patient Age54 YR
-
-